(FREMONT, Calif.)Biotech drug developer Aryx Therapeutics Inc. on Friday said Amgen executive David Beier has joined its board of directors. Beier handles government relations and corporate communi...READ MORE
(NEW YORK)Shares of Biotechnology company Aryx Therapeutics Inc. fell Thursday after Procter & Gamble abruptly ended its partnership on a developing gastrointestinal disorder drug.READ MORE
(NEW YORK)Biotechnology company Aryx Therapeutics Inc. said Wednesday Procter & Gamble abruptly pulled out of a partnership on a developing gastrointestinal disorder drug, despite positive s...READ MORE
(FREMONT, Calif.)Aryx Therapeutics Inc. said Monday an ongoing analysis of study results for its gastrointestinal disorder treatment candidate will prevent it from attending an upcoming investor co...READ MORE